GALENICA AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.85 CHF | +0.71% |
|
+0.93% | -2.61% |
| 04-17 | Switzerland's Galenica Issues CHF100 Million Bond Due 2031 | MT |
| 03-14 | GALENICA : FY23 one-offs shroud decent underlying profitability growth |  |
| Sales 2024 * | 3.92B 4.29B 343B | Sales 2025 * | 4.08B 4.46B 357B | Capitalization | 3.53B 3.86B 309B |
|---|---|---|---|---|---|
| Net income 2024 * | 174M 190M 15.24B | Net income 2025 * | 183M 200M 16.03B | EV / Sales 2024 * | 1.04 x |
| Net Debt 2024 * | 540M 590M 47.29B | Net Debt 2025 * | 510M 558M 44.67B | EV / Sales 2025 * | 0.99 x |
| P/E ratio 2024 * |
20.5
x | P/E ratio 2025 * |
19.3
x | Employees | 6,181 |
| Yield 2024 * |
3.22% | Yield 2025 * |
3.34% | Free-Float | 99.44% |
More Fundamentals
* Assessed data
More news
Latest transcript on Galenica AG
More recommendations
More press releases
More news
| 1 day | +0.71% | ||
| 1 week | +0.93% | ||
| Current month | -5.78% | ||
| 1 month | -4.71% | ||
| 3 months | -6.16% | ||
| 6 months | +6.30% | ||
| Current year | -2.61% |
1 week
69.70
71.40
1 month
69.3075.55
Current year
69.3078.15
1 year
65.1080.80
3 years
60.5582.20
5 years
47.5882.20
10 years
41.8082.20
| Managers | Title | Age | Since |
|---|---|---|---|
Marc Werner
CEO | Chief Executive Officer | 57 | - |
| Director of Finance/CFO | 58 | 31/12/16 | |
Lukas Ackermann
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/12/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Etienne Jornod
CEO | Chief Executive Officer | 71 | 31/12/95 |
Jörg Zulauf
BRD | Director/Board Member | 66 | 02/05/23 |
| Director/Board Member | 62 | 31/12/16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.18% | 5 M€ | -.--% | - | |
| 0.17% | 1,120 M€ | +0.40% | ||
| 0.07% | 773 M€ | -.--% | - | |
| 0.02% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 70.85 | +0.71% | 80,414 |
| 25/04/24 | 70.35 | -0.99% | 53,668 |
| 24/04/24 | 71.05 | +0.57% | 76,317 |
| 23/04/24 | 70.65 | -0.56% | 53,713 |
| 22/04/24 | 71.05 | +1.21% | 65,426 |
Delayed Quote Swiss Exchange, April 26, 2024 at 04:31 pm
More quotes
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
Pharmaceuticals
Calendar
05/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
70.85
CHF
Average target price
76.25
CHF
Spread / Average Target
+7.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.61% | 3.86B | |
| +17.35% | 71.39B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| +22.08% | 3.64B | |
| +7.96% | 3.29B |
- Stock Market
- Equities
- GALE Stock
